Lipid Sciences Inc (LIPD)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
LAND SUBDIVIDERS & DEVELOPERS (NO CEMETERIES)
CEO:
Employees:
7068 KOLL CENTER PARKWAY, SUITE 401, PLEASANTON, CA 94566
925-249-4000

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

N/A

View SEC Filings from LIPD instead.

View recent insider trading info

Funds Holding LIPD (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding LIPD

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Events (8k)

Proposed Sales (Form 144)

Proxy

Prospectus

All

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DJORDJEVIC BOSKO

  • Director
1,500,693 2008-05-20 0

RA CAPITAL MANAGEMENT, LLC

RA CAPITAL BIOTECH FUND LP

RA CAPITAL BIOTECH FUND II, L.P.

ALDRICH RICHARD

KOLCHINSKY PETER

  • 10% Owner
No longer subject to file 2008-03-27 0

BREWER H BRYAN JR

  • Director
50,000 2007-12-13 0

MEYER S LEWIS PRESIDENT, CEO AND DIRECTOR

  • Officer
  • Director
250,000 2007-12-03 0

RICHARDSON DALE L VP, BUSINESS DEVELOPMENT

  • Officer
220,000 2007-12-03 0

MALTAIS JO-ANN B VP, SCIENTIFIC AFFAIRS

  • Officer
185,000 2007-12-03 0

ROUBIN GARY S

  • Director
235,902 2007-12-03 0

PLACENTI FRANK M

  • Director
350,000 2007-12-03 0

GARDINER SANDRA CHIEF FINANCIAL OFFICER

  • Officer
140,000 2007-12-03 0

RENNECKAR STEPHEN E

  • Director
25,776 2007-06-07 0

RA CAPITAL MANAGEMENT, LLC

ALDRICH RICHARD

KOLCHINSKY PETER

RA CAPITAL BIOTECH FUND II, L.P.

  • 10% Owner
3,713,962 2007-03-01 0

RA CAPITAL MANAGEMENT, LLC

RA CAPITAL BIOTECH FUND LP

KOLCHINSKY PETER

ALDRICH RICHARD

  • 10% Owner
3,662,662 2006-12-21 0

POPE WILLIAM A

  • 10% Owner
6,554,888 2006-08-08 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments